CDH2 and head and neck squamous cell carcinoma: NOTCH4 showed a significant correlation with overexpression of specific mesenchymal markers, such as N-cadherin (CDH2), Vimentin, TWIST1, SOX2, Fibronectin, and downregulation of E-cadherin (CDH1) in patients with HNSCC.